Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Technology improves odds for critically ill

17.03.2008
Large numbers of unnecessary deaths and avoidable medical complications in intensive care units (ICU) are attributable to the difficulties of treating high glucose levels in critically ill patients’ blood. That is about to change for the better thanks to a new automated insulin delivery system developed by European researchers.

A common side effect of stress and trauma in critically ill patients is a rapid increase in blood glucose levels. As with diabetes, the levels can be reduced and controlled by the infusion of insulin. But glucose levels peak and change much more quickly in the ICU environment and there is little room for trial and error. If the situation is not normalised, then complications and even deaths can and do occur.

Twice in the past, Europe-wide studies and trials were put in place to try and come up with a solution to the problem. But in both cases they were prematurely halted because researchers could not solve the problem of overcompensating and patients developing hypoglycaemia, or abnormally low blood sugar levels.

“What these studies did clearly indicate is that the establishment of normal glucose levels in critically ill patients is very difficult to achieve without some sort of automated system to help the nurses,” says Dr Martin Ellmerer, scientific coordinator of the CLINICIP project which has developed just such a system.

Nurses’ no-nonsense approach
CLINICIP started by surveying ICUs in a number of European hospitals and interviewing nursing staff. “We found out that ICU staff did not want to see additional catheters in patients, they did not want extra equipment taking up space, and costs had to be kept right down so as not to eat into funds for other vital equipment,” says Ellmerer. “So, right from the start the requirements were really tough.”

Partners in this EU-funded project, academic medical institutions plus one private-sector medical equipment manufacturer, decided they needed to develop a two-step approach. “We first developed a decision-support system which met all the criteria outlined by the ICU staff, and later developed a fully automated system,” he tells ICT Results.

At the heart of both systems is a sophisticated bit of computer software (an algorithm) written especially for this project.

With the decision-support system, nurses still have to draw blood from patients in the traditional way and test it for glucose levels. They enter the information via the user interface – a touch screen – the researchers have developed. The algorithm takes over at this stage, calculates how much insulin is needed and automatically administers it. It also alerts the nurse when a new blood sample needs to be taken and analysed – half an hour in the worst cases and up to four hours in less severe cases.

“We have fully functioning prototypes of the decision-support system which we successfully trialled in ICUs at different hospitals around Europe,” Ellmerer says. The project’s industrial partner, B. Braun Melsungen AG, is ready to go into commercial production of the system working together with the clinical partners.

“We will first have to go through an approval process and the systems should be commercially available to hospitals in mid-2009,” Ellmerer says. B. Braun is one of the leading manufacturers of infusion systems used in hospitals, and the CLINICIP technology will be incorporated into these as it was during the trials.

Developing the real deal
At the same time the prototype was being developed and tested, CLINICIP researchers were working on sensors for a fully automated, closed-loop control system to both monitor glucose levels and administer insulin with no involvement from a nurse.

The drawback of this is that a dedicated needle is necessary. “Unfortunately, this is unavoidable for a fully automated system,” Ellmerer points out. Using fibre-optic technology the needle draws blood, sends it for analysis and then returns it to the patient’s vein as well as administering the necessary dose of insulin.

“We have performed a proof-of-concept study to show we are able to establish glucose control in a clinical setting,” Ellmerer says.

To develop the sensor technology further and then commercialise it, a spin-off company will be set up with Ellmerer as CEO and one of the shareholders. The other shareholders are individuals from project partners in CLINICIP. The spin-off will work closely with B. Braun and the partners, although they are not stakeholders in it.

Ellmerer expects the fully automated two-step system to be commercially available in 2011.

“Our research and the products which result from it should have a pretty fundamental impact on ICUs,” he says. “They should improve survival chances, reduce complications, such as sepsis and organ failure, and reduce the time patients need to spend in ICUs.”

Ahmed ElAmin | alfa
Further information:
http://cordis.europa.eu/ictresults/index.cfm/section/news/tpl/article/id/89612

More articles from Information Technology:

nachricht Putting food-safety detection in the hands of consumers
15.11.2018 | Massachusetts Institute of Technology

nachricht Next stop Morocco: EU partners test innovative space robotics technologies in the Sahara desert
09.11.2018 | Deutsches Forschungszentrum für Künstliche Intelligenz GmbH, DFKI

All articles from Information Technology >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>